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Cystic fibrosis (CF), a life-shortening hereditary disease 
mainly afflicting people of Caucasian origins, is caused by 
loss-of-function mutations in the CFTR (Cystic Fibrosis 
Transmembrane conductance Regulator) gene, which en-
codes a phosphorylation-activated, but ATP-gated anion 
channel expressed primarily in epithelial cells. To date, 
nearly 2000 mutations have been identified as pathogenic, 
but the deletion of a single amino acid phenylalanine at po-
sition 508 (i.e., deltaF508) accounts for ~70% of all dis-
ease-associated mutations and thus is present in at least one 
allele of ~90% of patients with CF. This mutation not only 
decreases the number of functional CFTR molecules in the 
plasma membrane due to defective folding of the del-
taF508-CFTR protein, but also disrupts ATP-dependent 
opening and closing (or gating) of the CFTR channel for the 
minor fraction of deltaF508-CFTR channels that do reach 
and stay in the cell membrane. While currently there is no 
cure for this debilitating disease, in the past decades, tre-
mendous efforts have been committed to developing rea-
gents that may help CFTR folding (i.e., correctors) or gating 
(i.e., potentiators). Recent successes in the discovery of an 
effective CFTR potentiator VX-770 (or Ivacaftor) and in its 
subsequent clinical trials not only establish an important 
precedent for realizing personalized medicine but also may 
serve as a stepping-stone for attaining the eventual goal of 
curing CF [1]. 
The CFTR protein, a member of the ATP Binding Cas-
sette (ABC) Transporter Superfamily, plays a pivotal role in 
transepithelial anion secretion and absorption in human 
body. In a host of exocrine tissues, activation of CFTR in 
the apical membrane of epithelial cells establishes an elec-
tric potential that drives the transepithelial movement of a 
counter ion such as sodium. The osmotic driving force aris-
ing from this transepithelial salt movement effects an ulti-
mate isotonic secretion into the lumen of the exocrine gland. 
Thus, loss of CFTR function by CF-associated mutations 
results in exocrine malfunction manifested in patients’ air-
ways, intestines, reproductive tracts, pancreas, and sweat 
glands. 
As an anion channel, CFTR also serves as a major path-
way for the secretion of bicarbonate in the pancreas, and 
hence dysfunction of the CFTR channel suffices to account 
for exocrine pancreatic abnormities in patients with CF. 
However, cystic fibrosis-related diabetes (CFRD), a comor-
bidity found in ~50% of adult CF patients, is an endocrine 
disorder that gravely affects the clinical outcomes of CF. 
Besides this practical consideration of CFRD in CF mortal-
ity and morbidity, the pathogenesis of CFRD is of interest 
in its own right. Although the causes for abnormal glucose 
metabolism in CFRD may be multifactorial, it is generally 
held that a diminished insulin secretion due to loss of pan-
creatic -cells in patients with CF is secondary to inflam- 
mation, fibrosis and destruction of the exocrine pancreas [2]. 
A recent study by Chan’s lab however may shift this para-
digm and shed new light in the pathogenesis of CFRD [3].  
In this report, the authors presented evidence for the ex-
istence of a cAMP-activated chloride conductance in iso-
lated mouse -cells. This whole-cell anion conductance 
shows all the hallmarks of CFTR and yet interestingly re-
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sponds to glucose, the physiological stimulus for insulin 
secretion. The mechanism underpinning glucose-induced 
insulin secretion has been well established previously: Glu-
cose increases cellular [ATP], which depolarizes the mem-
brane potential by closing ATP-sensitive potassium chan-
nels. A depolarized membrane potential subsequently acti-
vates voltage-gated calcium channels to increase intracellu-
lar [Ca], the final trigger for fusion of insulin-containing 
vesicles with the plasma membrane. However, in Guo et al. 
[3], pharmacological inhibition of CFTR not only hyperpo-
larizes the resting membrane potential, but also dramatically 
reduces the glucose-induced membrane depolarization, in-
dicating that basal CFTR activities play a critical role in 
determining the membrane potential in -cells. Indeed, the 
observation that CFTR inhibitors effectively abolish glu-
cose-induced membrane electrical activity and considerably 
reduce insulin secretion implicates an essential physiologi-
cal function of CFTR in -cells.  
Guo et al. [3] also took advantage of the CF mouse mod-
el by extending their studies to include -cells isolated from 
mice carrying the deltaF508 mutation. This line of investi-
gation further confirms an indispensible role of CFTR in 
-cell function and insulin secretion. More importantly, if 
these results in mouse cells can be replicated in human 
-cells, it means that pharmaceutical correction of CFTR 
dysfunction will surely lead to symptomatic improvement in 
patients afflicted by CFRD. Moreover, as the authors im-
plied in the report, the demonstration of a role of CFTR in 
insulin secretion also opens a new direction of research to-
wards a better understanding of the pathogenesis of diabetes 
in general, which constitutes a major health issues in the 
developed world. 
This work by Guo et al. [3] also bears significance far 
beyond its clinical implications in CF and diabetes. From a 
basic science angle, the study unveils several pertinent is-
sues warranting further investigations. First, abnormal glu-
cose metabolism is not regularly seen in CF mice or pigs, 
and even in human, CFRD is normally not observed in 
newborns and the incidence of CFRD increases as patients 
age. However, a recent study reported abnormal endocrine 
pancreas function at birth in CF ferrets [4]. It is therefore 
interesting to find out the mechanism underlying this ap-
parent species difference in the pathogenesis of CFRD. 
Second, in an intact cell, CFTR’s channel activity is usually 
thought to be mainly controlled by cAMP-dependent pro-
tein phosphorylation, while ATP-dependent gating does not 
play an active regulatory role as cellular [ATP] is nearly 
always maintained at a maximally effective concentration 
for CFTR gating. The observation that glucose can drasti-
cally modulate CFTR chloride conductance in -cells sug-
gests that a unique regulatory mechanism for CFTR gating 
is in place in these cells. Is the CFTR protein undergoing 
specific post-translational modification in -cells? Or do 
they interact with -cell specific associated proteins? Third, 
it has been shown that a volume-regulated anion conduct-
ance (VRAC) is involved in modulating the membrane ex-
citability of -cells [5]. Clearly the relative roles of VRAC 
and CFTR in insulin secretion await further illumination.  
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